ACO Reporting

Required ACO public reporting

ACO Name and Location

Pacific Private Practice Network, Inc
30230 Rancho Viejo Road, Suite 110
San Juan Capistrano, CA 92675

ACO Primary Contact

Primary Contact Name

Mary Olsovsky

Primary Contact Phone Number

949-441-5681

Primary Contact Email Address

[email protected]

Organizational Information

ACO PARTICIPANTS ACO Participant in Joint Venture (Enter Y or N)
ALAN R NILI DO A PROFESSIONAL CORPORATION N
ANAHEIM CARDIOLOGY MEDICAL GROUP INC N
ASHISH BHAVSAR, M.D., INC. N
CCOC, INC. N
FRANK ROSE N
Franklin Lowe Md, A Professional Medical Corporation N
Gabriel Carabulea, M.D., Inc. N
HELEN STOSEL MD INC N
Is Gujral Md N
Jason J Pang Md Inc N
JOHN LUSTER N
Judy L Bourget Md Inc N
Katherine Manasson M.D., Inc N
Mark Galbraith MD Inc N
Mark Zaremba, MD N
MARYAM RAHNEMUN MD INC N
Michael D. Moran, M.D., Inc. N
Michael Fitzgibbons MD N
Mission Hills Medical Group Inc N
Orange Family Medicine Inc N
Pacific Crest Medical Group Inc N
Paloma Medical Group Inc N
Proprius Health Medical Group PC N
RAVEEN R. ARORA MD FACC N
RONALD MANDEL N
SAN CLEMENTE INTERNAL MEDICAL GROUP INC N
SOUTH COAST MEDICAL GROUP FAMILY AND SPORTS MEDICINE N
Suma Oommen MD, Inc. N
TLC Allergy And Asthma Associates, Inc N
YOUR FAMILY CARE CENTER INC N

ACO governing body

Member Last Name Member First Name Member Title / Position Member’s Voting Power – Expressed as a percentage) Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Rovzar Michael CEO/Voting Member 25% ACO Participant Representative Paloma Medical Group
Kading Albert Voting Member 15% Medicare Beneficiary Representative N/A
Fitzgibbons Michael Voting Member 20% ACO Participant Representative Michael Fitzgibbons MD
Chang William Voting Member 20% ACO Participant Representative Paloma Medical Group
Cullen Steven Voting Member 20% ACO Participant Representative San Clemente Internal Medical Group

Key ACO clinical and administrative leadership:

Michael Rovzar ACO Executive
Michael Rovzar Medical Director
Mary Olsovsky Compliance Officer
Mary Olsovsky Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Quality Assurance and Process Improvement William Chang, MD, Chair
Patient Experience Albert Kading, Beneficiary Representative, Chair
Medical Cost and Provider Network Michael Fitzgibbons, MD, Chair
Finance and Compensation Michael Rovzar, MD, Chair
Utilization and Management William Chang, MD, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

First Agreement Period

  • Performance Year 2018, $0
  • Performance Year 2019, $0
  • Performance Year 2020, $0
  • Performance Year 2021, $0
  • Performance Year 2022, $0

Shared Savings Distribution

First Agreement Period

  • Performance Year 2018
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2020
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2019
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2021
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A
  • Performance Year 2022
  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

2021 Quality Performance Results

Quality performance results are based on CMS Web Interface

ACO# Measure Name Rate ACO Mean
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 6.69 10.71
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 70.13 76.97
236 Controlling High Blood Pressure 71.75 76.16
318 Falls: Screening for Future Fall Risk 80.72 87.83
110 Preventative Care and Screening: Influenza Immunization 75.29 77.34
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 90.00 79.27
113 Colorectal Cancer Screening 54.89 75.32
112 Breast Cancer Screening 59.66 78.07
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 53.60 86.37
321 CAHPS for MIPS3 N/A N/A
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 0.1440 0.1510
370 Depression Remission at Twelve Months 85.71 16.03
CAHPS -1 Getting Timely Care, Appointments, and Information 87.68 83.96
CAHPS -2 How Well Providers Communicate 92.87 93.47
CAHPS -3 Patient’s Rating of Provider 92.95 92.06
CAHPS -4 Access to Specialists 73.67 77.00
CAHPS -5 Health Promotion and Education 57.31 62.68
CAHPS -6 Shared Decision Making 56.60 60.97
CAHPS -7 Health Status and Functional Status 74.73 73.06
CAHPS -8 Care Coordination 85.44 85.46
CAHPS -9 Courteous and Helpful Office Staff 90.97 91.97
CAHPS -11 Stewardship of Patient Resources 26.75 25.62